SEC Filing Summary: Stellar Biotechnologies Inc.
Business Context and Reporting Period
This Form 6-K was filed by Stellar Biotechnologies Inc. (not Edesa Biotech, Inc.) for the month of June 2014, dated June 9, 2014. The registrant is a foreign issuer filing under Form 20-F. The filing primarily serves to disclose a change in the company's independent registered public accounting firm.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding auditor changes and does not contain financial statements or performance data.
Material Changes
The material change disclosed is the replacement of the company's independent auditor. The company notified the SEC of this change via Exhibit 99.1 dated June 3, 2014.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The primary risk or contingency highlighted is the transition of audit responsibilities. The company provided acknowledgments from both the departing auditor (Moss Adams LLP) and the new auditor (D&H Group LLP) as Exhibits 99.2 and 99.3.
Key Facts for Investor Verification
- Verify the reason for the change of auditor from Moss Adams LLP to D&H Group LLP.
- Confirm whether there were any disagreements with the former auditor on accounting principles or financial statement disclosures.
- Check subsequent filings for the first financial statements audited by the new firm.
- Note that the company name in the metadata (Edesa Biotech) differs from the registrant name in the filing (Stellar Biotechnologies).